T CELL IMMUNE RESPONSE INHIBITOR

摘要

The invention discloses a T cell immune response inhibitor. The inventive T cell immune response inhibitor includes nucleic acid vaccine with regard to pathogen and the protein antigen expressed by this nucleic acid vaccine; or includes nucleic acid vaccine with regard to pathogen and the active peptide of the protein antigen expressed by this nucleic acid vaccine; or includes inactivated pathogen and nucleic acid vaccine with regard to this pathogen. The inventive T-cell immune response inhibitor may provoke the body produce normal specific antibody immune response, restrain specific cell-mediated immune response, especially Th1 type immune response, thereby may be effectively used for autoimmune disease, organ transplantation, hypersensitivity, T cell amount controlled treatment.